Company Filing History:
6 out of 90 
1 out of 3 
1 out of 43 Years Active: 2000-2011
Title: The Innovations of David I Gwynne
Introduction
David I Gwynne is a notable inventor based in Beverly, MA (US). He has made significant contributions to the field of muscle disease treatment, holding a total of 8 patents. His work focuses on innovative methods that aim to improve the health and functionality of muscle tissues.
Latest Patents
Among his latest patents, Gwynne has developed methods for treating muscle diseases and disorders. These inventions relate to the administration of compounds that bind to the p185 receptor. The compounds have been found to enhance the differentiation and survival of cardiac, skeletal, and smooth muscle tissues. This groundbreaking approach has the potential to revolutionize treatments for various muscle-related conditions.
Career Highlights
Throughout his career, David I Gwynne has worked with prominent companies in the biotechnology sector. Notable among these are Acorda Therapeutics, Inc. and Cenes Pharmaceuticals, Inc. His experience in these organizations has allowed him to further his research and development efforts in muscle disease therapies.
Collaborations
Gwynne has collaborated with several professionals in his field, including Mark Andrew Marchionni and Robert Sklar. These partnerships have contributed to the advancement of his innovative projects and have fostered a collaborative environment for research and development.
Conclusion
David I Gwynne's contributions to the field of muscle disease treatment through his patents and collaborations highlight his dedication to innovation. His work continues to pave the way for new therapeutic approaches that can significantly impact patient care.